Interview with Mikel Arriola, Federal Commisioner, COFEPRIS
It’s been one year since you were appointed as Federal Commissioner of COFEPRIS in March 2011. What have been the biggest challenges you’ve faced within this time? The biggest challenge…
Address: Edificio Scotiabank Inverlat,Piso 12 / Blvd M. Avila Camacho ,1 1009 México D.F.,Mexico
Tel: 52 55 5279 2900
Web: http://www.bakermckenzie.com/Mexico/
Operating in Mexico for nearly 50 years, we have gained a deep understanding of local law and extensive experience assisting domestic and multinational companies. With five offices and a team of more than 240 seasoned professionals that includes lawyers, accountants and economists, we can bring the right talent to any kind of transaction within or outside Mexico. We are regularly involved in major M&A matters, privatization of government-owned companies, and complex financial transactions involving multiple jurisdictions.
We understand the importance of sharing our knowledge and resources, so we encourage and support our professionals in engaging in pro bono and community service activities. We give legal assistance to various charitable institutions, business and health organizations, carry out fund-raising activities to help nonprofit organizations, and participate in activities aimed at promoting good business practice and improving legal knowledge.
We are regularly involved in major M&A matters, privatization of government-owned companies, and complex financial transactions involving multiple jurisdictions.
It’s been one year since you were appointed as Federal Commissioner of COFEPRIS in March 2011. What have been the biggest challenges you’ve faced within this time? The biggest challenge…
Can you tell us a little about the history of Medix and about the company itself? Medix is a 100% Mexican company created in 1956, and our major strength is…
The last time we interviewed you was in 2008. Please can you tell our readers a little bit more about Liomont’s growth drivers and changes over these last four years?…
When we saw you in 2008 we had read a little bit about the major milestones in the company, how your grandfather came to Mexico in the 1950s and how…
Apotex has increased production, launched 16 new products last March, and grown significantly in the market. What would you say has been the biggest change in the market over the…
Please can you tell our readers a little bit more about the history of Stendhal, and its major milestones along the way since its takeover in 1997? Stendhal is a…
Carlos Garcia said in December 2009 that 6-8% of Novartis’ annual revenue comes from Latin America, and that the area is “one of the main growth engines for the company”.…
Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this acquisition affect Nycomed’s Latin…
The Mexican government has been fairly pro-active about promoting good practice such as the new drug registration process that helped eliminate drugs from the Mexican market that didn’t fulfill regulatory…
There have been quite a few regulatory changes in the last few years such as the new drug registration process and the suppression of the local plant rule. COFEPRIS has…
This is your 3rd interview with Focus Reports. What would you say has been the biggest change that has shaped the pharmaceutical industry since we last interviewed you in 2008?…
This is your third interview with Focus Reports. In 2004 and 2008 you were Director of AMIIF, before that you were Director of ANAFAM, and now we’re delighted to be…
See our Cookie Privacy Policy Here
